Urology Devices Market 2026-2035
Description
Urology Devices Market Size, Share & Trends Analysis Report by Product (Instruments and Consumables & Accessories) By Applications (Urological Cancer, Benign Prostate Hyperplasia, Kidney Disease, and Others) By End-user (Hospitals & Clinics, Dialysis Centers, and Research Institutions), Forecast Period (2026-2035)
Industry Overview
Urology devices market is expected to reach approximately $24.5 billion by 2035, growing at a CAGR of 8.6% from 2026 to 2035, up from $10.8 billion in 2025. The global urology device market is experiencing steady growth driven by the increasing prevalence of urological disorders, including kidney stones, benign prostatic hyperplasia, and urinary tract infections. Advances in minimally invasive surgical techniques and the adoption of robotic-assisted procedures have enhanced treatment outcomes, fueling demand for innovative devices. Rising awareness among patients and healthcare providers about early diagnosis and effective management of urological conditions is further contributing to market expansion. Additionally, the development of advanced diagnostic imaging and precision instrumentation supports the growing need for specialized urology interventions. Expansion of healthcare infrastructure in emerging economies and the availability of technologically advanced devices are also key factors.
Market Dynamics
Adoption of Minimally Invasive and Robotic-Assisted Procedures
The global urology device market is witnessing a growing shift toward minimally invasive surgical techniques, including laparoscopic and robotic-assisted procedures. These approaches offer reduced recovery times, lower complication rates, and improved precision, which has increased their acceptance among healthcare providers. As a result, demand for advanced surgical instruments, robotic systems, and associated consumables is rising steadily. Continuous innovation in device design and enhanced ergonomics for surgeons further support market expansion. Hospitals and specialty clinics are increasingly investing in such technologies to enhance patient outcomes.
Rising Demand for Advanced Diagnostic and Monitoring Solutions
Enhanced awareness of urological conditions has led to increased adoption of sophisticated diagnostic and monitoring devices. Imaging technologies, such as ultrasound, MRI, and CT-guided systems, alongside minimally invasive diagnostic tools, are facilitating early detection and better treatment planning. The integration of digital solutions and smart monitoring devices enables continuous patient tracking and improved clinical decision-making. Healthcare providers are prioritizing precision diagnostics to optimize therapeutic outcomes and reduce hospital stays. Additionally, the availability of portable and point-of-care diagnostic devices is expanding access in emerging regions.
Market Segmentation
Growth in the global urology devices market is increasingly supported by rising demand for advanced instruments used in diagnostic and therapeutic procedures. Hospitals and specialty centers are adopting modern endoscopic and surgical tools to enhance accuracy and reduce patient recovery time. Continued improvements in visualization, energy-based systems, and precision instruments have encouraged wider clinical use across a range of urological conditions. As treatment protocols evolve, clinicians are relying more on devices that offer greater efficiency and consistency in outcomes. This shift has strengthened investment in next-generation urology instruments.
Kidney Disease: A Key Segment in Market Growth
The global urology devices market is expanding as kidney-related disorders become increasingly common across many regions. Rising cases of chronic kidney disease and associated complications have led to greater use of diagnostic and therapeutic equipment in clinical practice. Healthcare providers are prioritizing early identification and timely management of renal conditions, which has elevated demand for specialized devices. Improvements in treatment techniques and broader availability of renal-care services have further supported this trend. Growing patient awareness and the need for reliable long-term care solutions also contribute to higher device utilization.
Regional Outlook
The global urology devices market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Increasing Adoption of Advanced Urological Technologies in Europe
The urology devices market in Europe is expanding as healthcare systems place greater emphasis on early diagnosis and effective management of urological conditions. Hospitals across the region are steadily incorporating modern surgical and diagnostic technologies to improve treatment precision and patient recovery. Rising awareness among clinicians and patients has encouraged broader use of specialized devices in both routine and complex procedures. Ageing populations in many European countries are also contributing to a higher demand for urology-related interventions. Continued investment in medical infrastructure and training supports further adoption of advanced equipment.
North America Region Dominates the Market with Major Share
The urology devices market in North America is advancing steadily as healthcare providers adopt newer technologies to support more precise and efficient treatment. Clinical centers are increasing their use of sophisticated diagnostic tools and surgical systems, reflecting a broader focus on improving outcomes for patients with urological conditions. Continuous upgrades in hospital equipment and strong investment in medical innovation have further encouraged the use of specialized devices. Growing clinical awareness and the availability of skilled practitioners contribute to the wider application of advanced techniques. The region’s structured healthcare networks also enable faster integration of emerging solutions.
Market Players Outlook
The major companies operating in the global urology devices market include B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Medtronic PLC, and Siemens Healthineers AG, among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
Industry Overview
Urology devices market is expected to reach approximately $24.5 billion by 2035, growing at a CAGR of 8.6% from 2026 to 2035, up from $10.8 billion in 2025. The global urology device market is experiencing steady growth driven by the increasing prevalence of urological disorders, including kidney stones, benign prostatic hyperplasia, and urinary tract infections. Advances in minimally invasive surgical techniques and the adoption of robotic-assisted procedures have enhanced treatment outcomes, fueling demand for innovative devices. Rising awareness among patients and healthcare providers about early diagnosis and effective management of urological conditions is further contributing to market expansion. Additionally, the development of advanced diagnostic imaging and precision instrumentation supports the growing need for specialized urology interventions. Expansion of healthcare infrastructure in emerging economies and the availability of technologically advanced devices are also key factors.
Market Dynamics
Adoption of Minimally Invasive and Robotic-Assisted Procedures
The global urology device market is witnessing a growing shift toward minimally invasive surgical techniques, including laparoscopic and robotic-assisted procedures. These approaches offer reduced recovery times, lower complication rates, and improved precision, which has increased their acceptance among healthcare providers. As a result, demand for advanced surgical instruments, robotic systems, and associated consumables is rising steadily. Continuous innovation in device design and enhanced ergonomics for surgeons further support market expansion. Hospitals and specialty clinics are increasingly investing in such technologies to enhance patient outcomes.
Rising Demand for Advanced Diagnostic and Monitoring Solutions
Enhanced awareness of urological conditions has led to increased adoption of sophisticated diagnostic and monitoring devices. Imaging technologies, such as ultrasound, MRI, and CT-guided systems, alongside minimally invasive diagnostic tools, are facilitating early detection and better treatment planning. The integration of digital solutions and smart monitoring devices enables continuous patient tracking and improved clinical decision-making. Healthcare providers are prioritizing precision diagnostics to optimize therapeutic outcomes and reduce hospital stays. Additionally, the availability of portable and point-of-care diagnostic devices is expanding access in emerging regions.
Market Segmentation
- Based on the product, the market is segmented into instruments and consumables & accessories.
- Based on the application, the market is segmented into urological cancer, benign prostate hyperplasia, kidney disease, and others.
- Based on the end-user, the market is segmented into hospitals and clinics, dialysis centers, and research institutions.
Growth in the global urology devices market is increasingly supported by rising demand for advanced instruments used in diagnostic and therapeutic procedures. Hospitals and specialty centers are adopting modern endoscopic and surgical tools to enhance accuracy and reduce patient recovery time. Continued improvements in visualization, energy-based systems, and precision instruments have encouraged wider clinical use across a range of urological conditions. As treatment protocols evolve, clinicians are relying more on devices that offer greater efficiency and consistency in outcomes. This shift has strengthened investment in next-generation urology instruments.
Kidney Disease: A Key Segment in Market Growth
The global urology devices market is expanding as kidney-related disorders become increasingly common across many regions. Rising cases of chronic kidney disease and associated complications have led to greater use of diagnostic and therapeutic equipment in clinical practice. Healthcare providers are prioritizing early identification and timely management of renal conditions, which has elevated demand for specialized devices. Improvements in treatment techniques and broader availability of renal-care services have further supported this trend. Growing patient awareness and the need for reliable long-term care solutions also contribute to higher device utilization.
Regional Outlook
The global urology devices market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Increasing Adoption of Advanced Urological Technologies in Europe
The urology devices market in Europe is expanding as healthcare systems place greater emphasis on early diagnosis and effective management of urological conditions. Hospitals across the region are steadily incorporating modern surgical and diagnostic technologies to improve treatment precision and patient recovery. Rising awareness among clinicians and patients has encouraged broader use of specialized devices in both routine and complex procedures. Ageing populations in many European countries are also contributing to a higher demand for urology-related interventions. Continued investment in medical infrastructure and training supports further adoption of advanced equipment.
North America Region Dominates the Market with Major Share
The urology devices market in North America is advancing steadily as healthcare providers adopt newer technologies to support more precise and efficient treatment. Clinical centers are increasing their use of sophisticated diagnostic tools and surgical systems, reflecting a broader focus on improving outcomes for patients with urological conditions. Continuous upgrades in hospital equipment and strong investment in medical innovation have further encouraged the use of specialized devices. Growing clinical awareness and the availability of skilled practitioners contribute to the wider application of advanced techniques. The region’s structured healthcare networks also enable faster integration of emerging solutions.
Market Players Outlook
The major companies operating in the global urology devices market include B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Medtronic PLC, and Siemens Healthineers AG, among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In November 2024, Boston Scientific Corp. acquired Axonics, Inc. The addition of Axonics’ sacral neuromodulation systems broadens Boston Scientific’s offerings in the treatment of urinary and bowel dysfunction.
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global urology devices market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
Table of Contents
267 Pages
- 1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Urology Devices Market Sales Analysis – Product Application End-User ($ Million)
- Urology Devices Market Sales Performance of Top Countries
- 1.1. Research Methodology
- Primary Research Approach
- Secondary Research Approach
- 1.2. Market Snapshot
- 2. Market Overview and Insights
- 2.1. Scope of the Study
- 2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Urology Devices Market Trends
- 2.2.2. Market Recommendations
- 2.3. Porter's Five Forces Analysis for the Urology Devices Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes
- 3. Market Determinants
- 3.1. Market Drivers
- 3.1.1. Drivers For Global Urology Devices Market: Impact Analysis
- 3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Urology Devices Market: Impact Analysis
- 3.3. Market Opportunities
- 4. Competitive Landscape
- 4.1. Competitive Dashboard – Urology Devices Market Revenue and Share by Manufacturers
- Urology Devices Product Comparison Analysis
- Top Market Player Ranking Matrix
- 4.2. Key Company Analysis
- 4.2.1. B. Braun Melsungen AG
- 4.2.1.1. Overview
- 4.2.1.2. Product Portfolio
- 4.2.1.3. Financial Analysis
- 4.2.1.4. SWOT Analysis
- 4.2.1.5. Business Strategy
- 4.2.2. Baxter International Inc.
- 4.2.2.1. Overview
- 4.2.2.2. Product Portfolio
- 4.2.2.3. Financial Analysis
- 4.2.2.4. SWOT Analysis
- 4.2.2.5. Business Strategy
- 4.2.3. Boston Scientific Corp.
- 4.2.3.1. Overview
- 4.2.3.2. Product Portfolio
- 4.2.3.3. Financial Analysis
- 4.2.3.4. SWOT Analysis
- 4.2.3.5. Business Strategy
- 4.2.4. Medtronic PLC
- 4.2.4.1. Overview
- 4.2.4.2. Product Portfolio
- 4.2.4.3. Financial Analysis
- 4.2.4.4. SWOT Analysis
- 4.2.4.5. Business Strategy
- 4.2.5. Siemens Healthineers AG
- 4.2.5.1. Overview
- 4.2.5.2. Product Portfolio
- 4.2.5.3. Financial Analysis
- 4.2.5.4. SWOT Analysis
- 4.2.5.5. Business Strategy
- 4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration
- 5. Global Urology Devices Market Sales Analysis by Product ($ Million)
- 5.1. Instruments
- 5.1.1. Endoscopes
- 5.1.2. Laser & Lithotripsy Devices
- 5.1.3. Robotic Systems
- 5.1.4. Others (Urodynamic System)
- 5.2. Consumables and Accessories
- 5.2.1. Dialysis Consumable
- 5.2.2. Guidewires
- 5.2.3. Surgical Dissectors
- 5.2.4. Others (Biopsy Devices, Stents)
- 6. Global Urology Devices Market Sales Analysis by Application ($ Million)
- 6.1. Urological Cancer
- 6.2. Benign Prostate Hyperplasia
- 6.3. Kidney Disease
- 6.4. Others
- 7. Global Urology Devices Market Sales Analysis by End-User ($ Million)
- 7.1. Hospitals and Clinics
- 7.2. Dialysis Centers
- 7.3. Research Institutions
- 8. Regional Analysis
- 8.1. North American Urology Devices Market Sales Analysis – Product Application End-User Country ($ Million)
- Macroeconomic Factors for North America
- 8.1.1. United States
- 8.1.2. Canada
- 8.2. European Urology Devices Market Sales Analysis – Product Application End-User Country ($ Million)
- Macroeconomic Factors for Europe
- 8.2.1. UK
- 8.2.2. Germany
- 8.2.3. Italy
- 8.2.4. Spain
- 8.2.5. France
- 8.2.6. Russia
- 8.2.7. Rest of Europe
- 8.3. Asia-Pacific Urology Devices Market Sales Analysis – Product Application End-User Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Australia & New Zealand
- 8.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 8.3.7. Rest of Asia-Pacific
- 8.4. Rest of the World Urology Devices Market Sales Analysis – Product Application End-User Country ($ Million)
- Macroeconomic Factors for Rest of the World
- 8.4.1. Latin America
- 8.4.2. Middle East and Africa
- 9. Company Profiles
- 9.1. B. Braun Melsungen AG
- 9.1.1. Quick Facts
- 9.1.2. Company Overview
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategies
- 9.2. Baxter International Inc.
- 9.2.1. Quick Facts
- 9.2.2. Company Overview
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategies
- 9.3. Becton, Dickinson and Company
- 9.3.1. Quick Facts
- 9.3.2. Company Overview
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategies
- 9.4. Boston Scientific Corp.
- 9.4.1. Quick Facts
- 9.4.2. Company Overview
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategies
- 9.5. Coloplast A/S Group
- 9.5.1. Quick Facts
- 9.5.2. Company Overview
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategies
- 9.6. ConvaTec Group PLC
- 9.6.1. Quick Facts
- 9.6.2. Company Overview
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategies
- 9.7. Cook Medical Inc.
- 9.7.1. Quick Facts
- 9.7.2. Company Overview
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategies
- 9.8. Devon Innovations Pvt. Ltd.
- 9.8.1. Quick Facts
- 9.8.2. Company Overview
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategies
- 9.9. Dornier MedTech GmbH
- 9.9.1. Quick Facts
- 9.9.2. Company Overview
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategies
- 9.10. Ethicon, Inc. (Johnson & Johnson Services, Inc.)
- 9.10.1. Quick Facts
- 9.10.2. Company Overview
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategies
- 9.11. Fresenius Medical Care AG
- 9.11.1. Quick Facts
- 9.11.2. Company Overview
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategies
- 9.12. Hollister Inc.
- 9.12.1. Quick Facts
- 9.12.2. Company Overview
- 9.12.3. Product Portfolio
- 9.12.4. Business Strategies
- 9.13. KARL STORZ SE & Co. KG
- 9.13.1. Quick Facts
- 9.13.2. Company Overview
- 9.13.3. Product Portfolio
- 9.13.4. Business Strategies
- 9.14. Medtronic PLC
- 9.14.1. Quick Facts
- 9.14.2. Company Overview
- 9.14.3. Product Portfolio
- 9.14.4. Business Strategies
- 9.15. Nikkiso Co., Ltd.
- 9.15.1. Quick Facts
- 9.15.2. Company Overview
- 9.15.3. Product Portfolio
- 9.15.4. Business Strategies
- 9.16. Nipro Corp.
- 9.16.1. Quick Facts
- 9.16.2. Company Overview
- 9.16.3. Product Portfolio
- 9.16.4. Business Strategies
- 9.17. Olympus Corp.
- 9.17.1. Quick Facts
- 9.17.2. Company Overview
- 9.17.3. Product Portfolio
- 9.17.4. Business Strategies
- 9.18. Richard Wolf GmbH
- 9.18.1. Quick Facts
- 9.18.2. Company Overview
- 9.18.3. Product Portfolio
- 9.18.4. Business Strategies
- 9.19. Siemens Healthineers AG
- 9.19.1. Quick Facts
- 9.19.2. Company Overview
- 9.19.3. Product Portfolio
- 9.19.4. Business Strategies
- 9.20. Teleflex Inc.
- 9.20.1. Quick Facts
- 9.20.2. Company Overview
- 9.20.3. Product Portfolio
- 9.20.4. Business Strategies
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
